Monograph

R03AC13 - Formoterol

Propably not porphyrinogenic

Rationale

Probably insignificant systemic exposure.

Chemical description

Adrenergic selective beta-2-stimulator with long durationof effect, administered as inhalation powder (12 Âµg/dose) in bronchial asthma. About 90% of the dose may be swallowed and absorbed. Plasma cancentrations are below the detection limit. Eliminated after direct glucuronidation and 0-demetylation followed by glucuronidation.

IPNet drug reports

Uneventful use reported in 4 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes R03A / R03AC or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames